Publications

Srivastava M, Singh S, Kumar P, Moond N, Chouhan A, Maan K, Kumari S, Banerjee M, Kushwah AS. From Epigenetic Dysregulation to Therapeutic Reprogramming in Endometrial Cancer: A State–Response Framework for Treatment Resistance. International Journal of Molecular Sciences 2026; 27(10), 4371-91. 

Singh S, Banerjee M, Kushwah AS. Personalized Neoantigen Cancer Vaccines: Why Clinical Benefit Remains Inconsistent. Critical Reviews in Oncology/Hematology 2026; 105336. 

Singh S, Nema R, Banerjee M, Kushwah AS. NLRP3 (NOD-, LRR-, and pyrin domain-containing protein 3) inflammasome at the crossroads of dysbiosis and disease: A target for microbiome-modulated inflammation. Gene & Protein in Disease 025180034. 

Masood S, Sharad P, Kushwah AS, Masood O, Banerjee M. MicroRNA and HPV oncogenes crosstalk, their biomarker potential and therapeutic utility in cervical cancer. Biomarkers in Medicine 2025; 1-13. (ISSN 1752-0363) (IF-2.1/Q2).

Vats P, Baweja B, Saini C, Kushwah AS, Kumar A, Srivastava SK, Nema R. An overview of CRISPR-artificial intelligence theranostics: Current and emerging applications. Biomaterials Translational 2025; 106. (ISSN 2096-112X) (Cite score – 9.8/Q1).

Masood S, Kushwah AS, Kirti Srivastava K, Banerjee M. Association of CDH1 gene variant C>A (rs16260) with expression and treatment outcomes in cervical cancer patients receiving chemoradiotherapy. Gene Reports 2025; 41:102344. (ISSN 2452-0144) (IF- 0.9/Q4).

Singh S, Nema R, Banerjee M, Kushwah AS*. Genetic and Epigenetic Landscape of O6-Methylguanine-DNA Methyltransferase (MGMT): Implications for DNA Repair and Cancer Therapeutics. Exploration of Targeted Anti-tumor Therapy 2025;6:1002335. (ISSN 2692-3114) (Cite score - 3.1/Q3).

Vats P, Saini C, Baweja B, Srivastava SK, Kumar A, Kushwah AS, Nema R. Aurora Kinases Signaling in Cancer: From Molecular Perception to Targeted Therapies. Molecular Cancer 2025; 24:180.  (ISSN No. 1476-4598) (IF – 33.9/Q1).

Kushwah AS, Gupta MK, Srivastava K, Banerjee M. Cytokine gene variants as Risk predictors and Prognostic biomarkers for cervix cancer: a revisit. Current Cancer Therapy Reviews 2025; 21:e15733947351277. (ISSN No. 1875-6301) (IF – 1.0/Q4).

Masood S*, Kushwah AS*, Anshika Yadav A, Singh P, Banerjee B. A Study on Socio-demographic-based Knowledge and Awareness for Cervical Cancer among Women from Uttar Pradesh, India. Clinical Epidemiology and Global Health 2024; 30:101825. (ISSN No. 2452-0918) (IF – 2.3/Q2)

Zaman N*, Kushwah AS*, Badriprasad A, Chakraborty G. Unravelling the Molecular Basis of PARP Inhibitor Resistance in Prostate Cancer with Homologous Recombination Repair Deficiency. International Review of Cell and Molecular Biology 2024; 389:257-301. (ISSN No. 1937-6448) (Cite Score – 6.4/Q1)

Shukla AS*, Shamsad A*, Kushwah AS*, Singh S, Usman K, Banerjee M. CD36 gene variant rs1761667 (G/A) as a biomarker in obese type 2 diabetes mellitus cases. Egyptian Journal of Medical Human Genetics 2024; 25(9): 1-8. (ISSN No. 2090-2441) (IF – 1.1/Q4)

Kushwah AS, Masood S, Rajnikant Mishra, Banerjee M. Genetic and epigenetic alterations in DNA repair genes and treatment outcome of chemoradiotherapy in cervical cancer. Critical Reviews in Oncology/Hematology 2024; 194:104240. (ISSN No. 1040-8428) (IF – 5.6/Q1)

Kushwah AS, Mishra R, Srivastava K, Banerjee M. Impact of human papillomavirus (HPV) infection on treatment outcome of concomitant chemoradiotherapy (CRT) in cervical cancer. Current Cancer Therapy Review 2023; 20(3):320-326. (ISSN No. 1875-6301) (IF – 0.9/Q4)

Gupta MK*, Kushwah AS*, Singh R, Srivastava K, Banerjee M. Genetic and epigenetic alterations in MGMT gene and correlation with concomitant-chemoradiotherapy (CRT) in cervical cancer. Journal of Cancer Research and Clinical Oncology (2023) 149:15159–15170.  (ISSN No. 1432-1335) (IF – 2.8/Q1)

Shukla N, Kumari S, Verma P, Kushwah AS, Banerjee M, Sankhwar SN, Srivastava A, Ansari MS, Gautam NK. Genotypic analysis of COL4A1 gene in diabetic nephropathy and type 2 diabetes mellitus patients: A comparative genetic study. DNA and Cell Biology 2023; 42(9):541-547. (ISSN No. 1557-7430) (IF – 2.6/Q2)

Kushwah AS, Srivastava K, Banerjee M. Differential expression of DNA repair genes and treatment outcome of chemoradiotherapy in cervical cancer. Gene 2023; 868:147389.  (ISSN No. 1879-0038) (IF – 2.8/Q2) (Research)

Shamsad A, Kushwah AS, Singh R, Banerjee M. Pharmaco-epi-genetic and patho-physiology of gestational diabetes mellitus (GDM): An overview. Health Sciences Review 2023; 7:100086. (ISSN No. 2772-6320) (Cite score - Q4)

Kushwah AS, Vats P, Usman K, Banerjee M. Risk prediction of type 2 diabetes mellitus (T2DM) in Indian families using antioxidant gene variants, Current Pharmacogenomics and Personalized Medicine 2022; 19(2): 100-111. (ISSN No. 1875-6913) (IF – 0.4/Q4)

Kushwah AS, Mishra R, Srivastava K, Mishra S, Banerjee M. Anthro-demographic, clinico-pathological and biochemical risk factors in cervical cancer. International Journal of Health Sciences 2022; 6(S8): 3641-3653. (ISSN No. 2550-696X) (Cite Score–2.0/Q4)

Kushwah AS, Mishra R, Shukla AK, Banerjee M. Combinatorial therapy of Cynodon dactylon and metformin with Cisplatin in cervical cancer. Journal of Scientific Research 2021; 66(4):35-41. (ISSN No. 0447-9483) (IF – 0.2/Q4)

Kaushik M, Joshi RC, Kushwah AS, Gupta MK, Banerjee M, Burget R, Dutta MK. Cytokine gene variants and sociodemographic characteristics as predictors of cervical cancer: a machine learning approach. Computers in Biology and Medicine 2021; 134:104559. (ISSN No. 1879-0534) (IF – 6.3/Q1)

20.   Kushwah AS, Gupta MK, Singh R, Banerjee M. Cytokine gene variants and treatment outcome of cisplatin-based concomitant chemoradiotherapy in cervical cancer. British Journal of Biomedical Science 2020; 77(2):81-86. (ISSN No. 2474-0896) (IF – 4.6/Q1) (Research)

Gupta MK, Kushwah AS, Singh R, Banerjee M. Genotypic analysis of XRCC4 and susceptibility to cervical cancer. British Journal of Biomedical Science 2020; 77(1):7-12. (ISSN No. 2474-0896) (IF – 4.6/Q1)

Banerjee M, Vats P, Kushwah AS, Srivastava N. Interaction of antioxidant gene variants and susceptibility to type 2 diabetes mellitus. British Journal of Biomedical Science 2019; 76(4):166-171. (ISSN No. 2474-0896) (IF – 4.6/Q1)

Singh S, Mishra G, Kushwah AS, Banerjee M. Evidence of genetic heterogeneity in communities from Uttar Pradesh using IL-1RN gene polymorphism. International Journal of Recent Scientific Research 2018; 9(1): 23412-23415. (ISSN No. 0976-3031) (IF - 1.3/Q4)

Vats P, Kushwah AS, Banerjee M. Association of antioxidant gene variants with type 2 diabetes mellitus in different ethnic groups. European Journal of Biomedical and Pharmaceutical Sciences 2017; 4(9): 290-298. (ISSN No. 2349-8870) (IF - 0.7/Q4)